Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $30.1 million.

  • AtriCure's Net Cash Flow rose 2506.75% to $30.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.3 million, marking a year-over-year decrease of 6505.44%. This contributed to the annual value of $38.8 million for FY2024, which is 4783.59% up from last year.
  • AtriCure's Net Cash Flow amounted to $30.1 million in Q3 2025, which was up 2506.75% from $17.4 million recorded in Q2 2025.
  • In the past 5 years, AtriCure's Net Cash Flow ranged from a high of $43.6 million in Q1 2021 and a low of -$27.6 million during Q3 2021
  • Over the past 5 years, AtriCure's median Net Cash Flow value was $3.9 million (recorded in 2021), while the average stood at $5.6 million.
  • Its Net Cash Flow has fluctuated over the past 5 years, first soared by 76106.22% in 2021, then crashed by 29758.53% in 2024.
  • AtriCure's Net Cash Flow (Quarter) stood at $3.9 million in 2021, then skyrocketed by 132.43% to $9.0 million in 2022, then plummeted by 60.1% to $3.6 million in 2023, then tumbled by 297.59% to -$7.1 million in 2024, then surged by 522.74% to $30.1 million in 2025.
  • Its Net Cash Flow was $30.1 million in Q3 2025, compared to $17.4 million in Q2 2025 and -$23.0 million in Q1 2025.